Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Fujitsu and Tokai National System use AI to speed up patient selection for clinical trials in Japan, aiming to improve drug access.
Fujitsu and Tokai National Higher Education and Research System have completed field trials using AI to process clinical data for selecting clinical trial participants in Japan.
This aims to address the issue of 'drug loss,' where drugs available overseas are not locally available due to strict approval processes.
The trials, using data from about 1,800 patient records, achieved 90% accuracy in structuring data, speeding up patient selection and improving access to clinical trials.
Future plans include expanding the scope and improving accuracy, with integration into clinical trial platforms to enhance data use and collaboration.
Fujitsu y Tokai National System utilizan la IA para acelerar la selección de pacientes para ensayos clínicos en Japón, con el objetivo de mejorar el acceso a los medicamentos.